New Oncological Products

Implementing innovation activities so as to create a new oncological product portfolio for Egis Pharmaceuticals PLC.
START DATE: 2008-10-08

Target

● Introduction of oncological portfolio of new products, developed by 2011, into national and international markets—resulting in significant profits and cost savings for Hungarian public drug reimbursement.
● To achieve an indirect public health benefit from larger numbers of oncology patients receiving treatment—whilst using the same reimbursement funding in oncology.

Results

● During the project, we performed the activities relating to the professional tasks of industrial property rights and registration and business development—as required in order to obtain the licenses of the planned oncological products.
● Within the framework of the project, Egis Pharmaceuticals PLC established a new laboratory for the analytical testing of oncological products. Special automated equipment and instruments were purchased for the testing of oncological products containing priority hazardous substances. With the establishment of the new laboratory, we have created new, modern R&D infrastructure at the company, that not only allows the analytical testing of license products, but also enables the analytical development activities that are required to produce oncological products that we ourselves have developed—thus contributing to the implementation of the company's new research strategy.
● The new products of the oncology portfolio—comprising seven generic products, as developed by 2011—appeared on the domestic and international markets.
● The efficay of the active substances of these new products was proven in clinical trials. These products outperform those previously available—due to their improved survival rates, tolerability and adverse effects profile.
● Another advantage of the application of these new drugs is that by using less-costly generic products, more patients can be treated from the financial support framework, and the health insurance system can provide new, innovative therapies for patients.

Description

Information on the proposed project:

● Principal of the tender: National Development Agency
● Title and code of the call for tender proposals: “Supporting corporate innovation”, KMOP-2008-1.1.4
● Title and ID of proposed project: “New oncological products”, KMOP-1.1.4-08/1-2008-0005
● Submission date of proposal: 07/10/2008
● Date of decision about funding: 22/12/2008
● Granted amount: HUF 159,560,500
● Time period for project implementation: 08/10/2008 - 07/11/2011
● Total costs of the project: HUF 638,242,000
● Provided funding: HUF 130,427,133

Details

    Contact details in relation to the project:
Beneficiary's name and contact
Egis Pharmaceuticals PLC
1106 Budapest, Keresztúri út 30-38.
Phone: 06-1-803-5555
http://www.egis.hu
Intermediate Body's name and contact
Hungarian State Treasury
Department for Regional Development Programs
1139 Budapest, Váci út 71.
Phone: +36-1-452-8690
ropinfo@allamkincstar.gov.hu
Managing Authority's name and contact
Ministry of National Economy
Deputy State Secretariat for the Implementation of Economic Development Programs
1139 Budapest, Váci út 83.
Phone: +36-1-896-6666
www.palyazat.gov.hu

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox